Kristian Werling

Practice Areas

Kristian (Krist) Werling represents private equity and strategic investors in a wide variety of transactional matters in the healthcare and life sciences industry. In this capacity, he works with cross-disciplinary teams to conduct legal due diligence and execute acquisitions and divestitures as well as provide ongoing legal services to portfolio companies. Krist is a co-head of the Firm’s Private Equity Practice Group and serves as an elected member of the Firm’s Management Committee.

Clients look to Krist for his ability to lead teams of lawyers that develop creative transaction structures that enable deals to close. In the healthcare services arena, Krist has particular experience with transactions and joint ventures involving physician practice management, ambulatory surgical centers, specialty hospitals, dermatology, pain management and anesthesia physician practices and dental practice management companies. He also has deep experience in life sciences transactions, including pharmaceutical and biotechnology licensing and collaboration, product-line carve-outs and pharmaceutical services investments.

Krist had several years of experience serving as in-house counsel to Hospira, Inc., a generic specialty pharmaceutical and medical device manufacturer that was sold to Pfizer.

View more at: https://www.mwe.com/people/werling-kristian-a/

Professional Memberships

American Health Lawyers Association, former chair of the Life Science Practice Group, and editor in chief of the second edition of The Fundamentals of Life Sciences Law: Drugs, Devices, and Biotech

Work Highlights

Ampersand Capital Partners in a wide variety of transactions including the acquisition of New England Peptides, Peptides International, Tjoapack, Canopy Biosciences, Zellwerkraft, Adaptas/ETP Ion Detect, Cadence Fluidics, Pharma Packaging Solutions, Applied Kilovolts, Genome Diagnostics and Sanova Dermatology as well as the sale of Adaptas Solutions to IMI Plc

Amulet Capital Partners in a wide variety of transactions including the formation of and investment in US Fertility through the acquisition of Integramed and Shady Grove Fertility as well as the formation and investment in Children’s Choice Dental Management, Children’s Choice Dental Management, Dental Brands, Children’s Dental Support Services, LLC and Desert Valley Pediatric Dentistry as well as the formation of US Fertility